# Phage Therapy for Recurrent UTIs in Kidney Transplant Recipients

> **NCT06409819** · PHASE1,PHASE2 · RECRUITING · sponsor: **University of California, San Diego** · enrollment: 32 (estimated)

## Conditions studied

- Urinary Tract Infection, Recurrent

## Interventions

- **DRUG:** phage therapy
- **DRUG:** control

## Key facts

- **NCT ID:** NCT06409819
- **Lead sponsor:** University of California, San Diego
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-06-15
- **Primary completion:** 2026-10-01
- **Final completion:** 2027-03-01
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2025-08-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06409819

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06409819, "Phage Therapy for Recurrent UTIs in Kidney Transplant Recipients". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06409819. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*